By Divya Ramaswamy
Key Points
With more than 21,000 American … Read more
By Christina Bennett, MS
Regardless of birthplace, women who are Asian Pacific Islanders may have a higher risk of developing ovarian clear cell cancer compared with other ethnicities, according to a population-based retrospective cohort study. The findings were recently published … Read more
By Sharon Worcester
REPORTING FROM THE CLINICAL IMMUNO-ONCOLOGY SYMPOSIUM
By Peter Hofland, Ph.D
Scientists at the Medical University of South Carolina (MUSC) and the University of California at San Diego (UCSD) are shedding light on a decades-old controversy, showing that autophagy or “self-eating” genes work against tumors … Read more
By Kate O’Rourke
San Francisco—Results from a pilot study evaluating two treatment schedules of a standardized Swedish massage technique to treat chemotherapy-induced peripheral neuropathy (CIPN) showed that both massage two and three times per week could reduce CIPN-related symptoms. The … Read more
Cancer cells operate in mutational overdrive, which allows them to blow past chemotherapy and other would-be enforcers of physiological order. Cancer’s speeding, however, may prove to be a vulnerability, say scientists from the Mayo Clinic, the Institute of Cancer Research, … Read more
By Susan Moench, PhD, PA-C
A central tenant of a recently issued American Society of Clinical Oncology (ASCO) guideline is that all women with a diagnosis of epithelial ovarian cancer should be offered testing for specific germline mutations associated with … Read more
By Kashmira Gander
Taking a single dose of a psychedelic compound found in magic mushrooms can ease symptoms of anxiety and depression in cancer patients for years, according to a study.
Almost five years after taking the compound psilocybin while … Read more
By Julie Steenhuysen
(Reuters Health) – U.S. researchers who tested the cancer-fighting properties of more than 4,500 non-cancer drugs found nearly 50 drugs for other conditions showed at least some cancer-killing ability.
“We found that a surprising number of non-oncology … Read more
By Sharon Begley
As every trauma surgeon knows, there are messy bullet wounds and there are neat ones, and the former cause incomparably more trouble. If a team of scientists in China is right, the same principle may explain why … Read more
About 14,000 women each year die of ovarian cancer, making it one of the deadliest gynecologic cancers.
Moreover, 80% of ovarian cancer diagnoses occur only after the disease has progressed to a late stage. The Ovarian Cancer Research Alliance estimated … Read more
By Kashmira Gander
Scientists have discovered a new cell in the immune system that can kill many types of cancer, which they hope could one day be used to create a “one size fits all” treatment for the disease.
In … Read more
By Christina Bennett, MS
Germline PALB2 pathogenic variants were associated with an increased risk for female breast cancer, male breast cancer, ovarian cancer, and pancreatic cancer, and these risks varied by age, according to data from an international study … Read more
By Ian Ingram
— With some 250,000 participants, study rules out all but smallest risk increases
New research on a quarter-million women from four U.S. cohorts found no significant association between ovarian cancer and the use of powder-based products in … Read more
Clearity’s Clinical Trial Finder is a personalized and online search tool that will help you to find a clinical trial based on your location or clinical situation (i.e. platinum sensitive or platinum resistant, number of previous treatments). We can also … Read more
By Jeanne Rawdin
“Elegant science” are not two words you hear put together very often. But for Carmel Valley resident Dr. Pamila Brar the phrase sums up her life’s career goals. Brar sees elegant science as “the promise of precision … Read more
This article discusses the anxiety that often surrounds routine appointments, as well as daily life, after a cancer diagnosis. Steps Through OC offers free, professional ovarian cancer counseling for women, families and caregivers coping with ovarian cancer. Our goal is … Read more
By Matthew Fowler
Weekly dose-dense paclitaxel as a frontline treatment for patients with epithelial ovarian cancer was not found to significantly improve progression-free survival (PFS) compared to the standard 3-weekly chemotherapy, according to results from the ICON8 study published in … Read more
By Nichole Tucker
Preliminary data showed that the combination of sitravatinib (MGCD516) and tislelizumab (BGB-A317) is well tolerated and may promote antitumor activity when administered to patients with platinum-resistant ovarian cancer, according to a press release from BieGene, Ltd, which … Read more
By Marissa Wexler, MS
Endometriosis does not seem to significantly affect ovarian cancer prognosis and survival in patients of reproductive age, a small study suggests.
However, more research is needed to identify factors associated with the progression of endometriosis to … Read more
